Session Chair "Capital Markets: A Critical Factor in Any Innovation Economy"

In his professional career, Dr. Chen has made numerous contributions in assessing technology, transferring discoveries into the clinic, raising venture investment and establishing strategic partnerships among pharmaceutical and biotech companies.  Previously Dr. Chen built talented scientific teams in various scientific disciplines at Roche Diagnostics, Sentinel Biosciences, Progenesys, and SyStemix (a Novartis company).  Dr. Chen studied at the University of Wisconsin-Madison and Stanford University.